Nalaganje...

Tardive dyskinesia with low dose amisulpride

In recent years, there has been an increasing trend to use amisulpride in the treatment of dysthymia and also as an adjunct treatment in patients with major depression. At low doses (50 mg), amisulpride preferentially blocks presynaptic auto receptors, enhances dopamine release, and therefore acts a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tharoor, Hema, Padmavati, R.
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574463/
https://ncbi.nlm.nih.gov/pubmed/23440033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5545.105523
Oznake: Označite
Brez oznak, prvi označite!